Anzhou Xia
Overview
Explore the profile of Anzhou Xia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang S, Xu X, Huang Y, Sun S, Jin C, Ji H, et al.
Pharmazie
. 2021 May;
76(5):220-224.
PMID: 33964996
Anisodamine exerts significant protective effect on ischemia/reperfusion (I/R) injury in various organs. However, little is known about the mechanisms of anisodamine in renal I/R injury. Activation of extracellular regulated protein...
2.
Wang Y, Wang Y, Li Y, Lu L, Peng Y, Zhang S, et al.
Exp Ther Med
. 2020 Sep;
20(5):17.
PMID: 32934682
Renal interstitial fibrosis (RIF) is a common pathological process that accompanies chronic kidney disease (CKD) and that progresses to end-stage renal failure (ESRD). Accumulating evidence has revealed that persistent mammalian...
3.
Lu L, Zhu J, Zhang Y, Wang Y, Zhang S, Xia A
Mol Med Rep
. 2019 Jan;
19(3):1694-1704.
PMID: 30628645
Our previous study demonstrated that febuxostat, a xanthine oxidase inhibitor, can alleviate kidney dysfunction and ameliorate renal tubulointerstitial fibrosis in a rat unilateral ureteral obstruction (UUO) model; however, the underlying...
4.
Xia A, Li H, Li R, Lu L, Wu X
Oncol Rep
. 2018 Aug;
40(4):2353-2362.
PMID: 30066933
The activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling and upregulation of excision repair cross complementation group 1 (ERCC1) are the two most important factors...
5.
Zhang Y, Li H, Zhu J, Wei T, Peng Y, Li R, et al.
Mol Med Rep
. 2017 Oct;
16(6):8891-8899.
PMID: 28990102
The implications of epithelial‑mesenchymal transdifferentiation (EMT) have extended beyond the confines of renal fibrosis to renal tubulointerstitial fibrosis. It has been proposed that EMT may be one of the mechanisms...
6.
Cao J, Wang W, Li Y, Xia J, Peng Y, Zhang Y, et al.
Int Urol Nephrol
. 2016 Feb;
48(4):619-29.
PMID: 26865179
Purpose: Kidney fibrosis is the most common final stage of progressive renal disease. Bone morphogenetic protein-7 (BMP-7) has been shown to be important in both preservation of kidney function and...
7.
Cao J, Li Y, Peng Y, Zhang Y, Li H, Li R, et al.
Am J Nephrol
. 2015 Dec;
42(5):369-78.
PMID: 26680283
Background: Renal interstitial fibrosis (RIF) is a common pathology associated with end-stage renal diseases. The activation of bone morphogenetic protein-7 (BMP-7)-Smad1/5/8 pathway seems to alleviate RIF. Uterine sensitization-associated gene-1 (USAG-1),...
8.
Xia A, Xue Z, Li Y, Wang W, Xia J, Wei T, et al.
Evid Based Complement Alternat Med
. 2014 Jun;
2014:573745.
PMID: 24963326
Objectives. This study aims to investigate the effect of betulinic acid (BA) on myocardial ischemia reperfusion/injury in an open-chest anesthetized rat model. Methods. The model was induced by 30 minutes...
9.
Xia A, Li Y, Li N, Xue Z, Xia J, Wei T, et al.
Int Urol Nephrol
. 2014 Jun;
46(7):1455-64.
PMID: 24927932
Purpose: Ischemic postconditioning is a procedure during which intermittent reperfusions are performed in the early phase of reperfusion to protect organs from ischemia/reperfusion injury. And in this study, we mainly...
10.
Xia A, Xue Z, Wang W, Zhang T, Wei T, Sha X, et al.
Korean J Physiol Pharmacol
. 2014 Mar;
18(1):67-72.
PMID: 24634599
To investigate the alteration of c-Jun N-terminal kinase (JNK) activity after myocardial ischemia reperfusion injury (MIRI) and further explore the effect of naloxone postconditioning on MIRI. Forty male Sprague Dawley...